Apolipoprotein E, statins, and risk of intracerebral hemorrhage

Stroke

Volumn 44, Issue 11, 2013, Pages 3013-3017

  Woo, Daniel ^a   Deka, Ranjan ^a   Falcone, Guido J ^b,c   Flaherty, Matthew L ^a   Haverbusch, Mary ^a   Martini, Sharyl R ^a   Greenberg, Steven M ^b   Ayres, Alison M ^b   Sauerbeck, Laura ^a   Kissela, Brett M ^a   Kleindorfer, Dawn O ^a   Moomaw, Charles J ^a   Anderson, Christopher D ^b,c   Broderick, Joseph P ^a   Rosand, Jonathan ^b,c   Langefeld, Carl D ^d   Woo, Jessica G ^e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d WAKE FOREST UNIVERSITY   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein E; Epidemiology; Genetics; Hydroxymethylgutaryl CoA reductase inhibitors; Intracerebral hemorrhage; Pharmacogenomics

Indexed keywords

AMLODIPINE PLUS ATORVASTATIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ATORVASTATIN; CERIVASTATIN; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ALLELE; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CHOLESTEROL METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; NORMOCHOLESTEROLEMIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; REPLICATION STUDY; RISK FACTOR; SINGLE BLIND PROCEDURE; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEIN E; EPIDEMIOLOGY; GENETICS; HYDROXYMETHYLGUTARYL-COA REDUCTASE INHIBITORS; INTRACEREBRAL HEMORRHAGE; PHARMACOGENOMICS;

AGED; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84888298595     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001304     Document Type: Article

References (24)

1. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35:426-431.
2. Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA. Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients: institutional and geographical differences. J Neurosurg. 1997;86:583-588.
3. Konishi M, Ozawa H, Iida M, Simamoto T, Ueshima H. Epidemiological studies of cerebro- and cardiovascular diseases in the northeast of Japan Part I. Pathological approach to the study in Akita Prefecture. Jpn Circ J. 1976;40:723-728.
4. Ueda K, Hasuo Y, Kiyohara Y Wada J, Kawano H, Kato I, et al. Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke. 1988;19:48-52.
5. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke. 1989;20:1460-1465.
6. Jacobs DR. The relationship between cholesterol and stroke. Health Rep. 1994;6:87-93.
7. Thrift A, McNeil J, Donnan G; Melbourne Risk Factor Study Group. Reduced frequency of high cholesterol levels among patients with intracerebral haemorrhage. J Clin Neurosci. 2002;9:376-380.
8. Woo D, Kissela BM, Khoury JC, Sauerbeck LR, Haverbusch MA, Szaflarski JP, et al. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study. Stroke. 2004;35:1360-1364.
9. Martini SR, Flaherty ML, Brown WM, Haverbusch M, Comeau ME, Sauerbeck LR, et al. Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology. 2012;79:2275-2282.
10. Goldstein LB, Amarenco P, Szarek M, Callahan A III, Hennerici M, Sillesen H, et al; SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2008;70(24 pt 2):2364-2370.
11. McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 2012;43:2149-2156.
12. Westover MB, Bianchi MT, Eckman MH, Greenberg SM. Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol. 2011;68:573-579.
13. Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002;33:1190-1195.
14. Group GfCHoAGC. Exploiting common genetic variation to make anticoagulation safer. Stroke. 2009;40:S64-S66.
15. Flaherty ML, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36:934-937.
16. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993;11:575-580.
17. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy [see comments]. Ann Neurol. 1995;38:254-259.
18. McCarron M, Nicoll J. High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage. Neurosci Lett. 1998;247:45-48.
19. Corder E, Saunders A, Risch N, Strittmatter WJ, Schmechel DE, Gaskell PC Jr et al. Protective effect of apolipoprotein E type 2 allele for late onset alzheimer disease. Nat Genet. 1994;7:180-184.
20. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
21. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb. 1991;11:1237-1244.
22. Sheehan D, Bennett T, Cashman K. Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk. Ir J Med Sci. 2000;169:50-54.
23. Hill JS, Hayden MR, Frohlich J, Pritchard PH. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb. 1991;11:290-297.
24. Strittmatter WJ. Medicine. Old drug, new hope for Alzheimer's disease. Science. 2012;335:1447-1448. Stroke